News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
PrEP
New Advocacy Group Wants to Improve Feasibility of PrEP for U.S. Women

Following disappointing results from the VOICE trial released at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, a new U.S. Women and PrEP Working Group has called on the federal government to help American women use antiretroviral pre-exposure prophylaxis (PrEP) safely and effectively. But the AIDS Healthcare Foundation (AHF) responded by urging the Food and Drug Administration to rescind its approval of Truvada (tenofovir/emtricitabine) for HIV prevention.

Published
23 hours ago
From
HIVandHepatitis.com
Clinical trials
Testing HIV Prevention Tools: Other Ways Up the Alley

We need to design prevention trials that ask, “Is this test product better than nothing?” rather than, “Is this test product better than the best available prevention combination we have?”

Published
15 March 2013
From
Poz
PrEP
Preventing HIV Infection With Anti-HIV Drugs in People at Risk Is Cost-Effective

An HIV prevention strategy in which people at risk of becoming exposed to HIV take antiretroviral drugs to reduce their chance of becoming infected (often referred to as pre-exposure prophylaxis or PrEP), may be a cost-effective method

Published
13 March 2013
From
Science Daily
PrEP
Mitchell Warren: Listening to Women's Voices on HIV Prevention

The VOICE trial results show that we still have a lot to learn about what women really want and need in HIV prevention. The women in the trial are telling us something that is true for every group at risk for HIV: to help more people avoid infection, we need to offer prevention tools they will actually want, demand and use.

Published
12 March 2013
From
Huffington Post
Condoms and lubricant
Putting the Nail in the Coffin of Condom-Only HIV Prevention

Dearly beloved, we gather here to say our goodbyes. For over thirty years, condoms have been our only lifesavers in the face of HIV. But as if we needed any additional evidence of the need to turn the page, it came in the form of a seemingly banal conference presentation this week in Atlanta at the 20th Conference on Retroviruses and Opportunistic Infections.

Published
08 March 2013
From
Frontiers LA
PrEP
CROI 2013: iPrEx Update—A Q&A with Dr. Robert Grant

What happens when access to PrEP is interrupted? Will PrEP prove to have merely delayed HIV acquisition in people at high risk for infection?

Published
07 March 2013
From
BETA blog
Adherence
CROI 2013: The VOICE Results—A Social Scientist’s Perspective

To social scientist Judith D. Auerbach, PhD, a consultant to the NIH Office of AIDS Research and San Francisco AIDS Foundation, the VOICE results raise a number of questions—but not the ones you might think.

Published
06 March 2013
From
BETA blog
PrEP
After VOICE trial, question remains: What were women telling researchers?

The results were disappointing in every way: the products evaluated were not shown to be effective, the adherence to using the products was dismal – and cancelling the possibility of learning if the products conferred any protection, it was worst among the demographic at highest risk — the younger, unmarried women.

Published
05 March 2013
From
Science Speaks
PrEP
Statements on the VOICE results

Comments on the disappointing vaginal microbicide and PrEP results from AVAC, the Gates Foundation, the NIH, and others.

Published
05 March 2013
From
AVAC
PrEP
CROI 2013: Learning from the PrEP Access “Gap” in the iPrEx Trial

Demonstration projects are launching across the country and around the world to evaluate how best to make PrEP available in the real world, but another important question is this: What happens when PrEP becomes unavailable to people who are already using it?

Published
05 March 2013
From
BETA blog
← First12345...24Next →

Filter by country